All
Talzenna-Novel Drug Combo Continues to Be Studied in Patients With Triple-Negative Breast Cancer
May 12th 2022Findings from an early-stage trial assessing Talzenna in combination with a novel drug, known as ZEN-3694, have led the manufacturer to initiate a later-stage study in patients with triple-negative breast cancer.
Educating Patients About Cancer Should Not Be a ‘One-Size-Fits-All’ Approach, Says Expert
May 11th 2022When it comes to learning about their disease, patients with cancer can have different preferences, from wanting to discuss treatments with their providers or read handouts, while others may not want to know much at all.
One Nurse’s Devotion to Cancer Has Healed Many Patients
May 10th 2022“I feel her strength, and because of Lorelei — the way she makes me feel comfortable and confident; the way she cares deeply for me, her other patients and colleagues; and her always professional attitude and manner — I realize that, like other obstacles, I will eventually be able to face this, too,” writes one nurse’s patient in an essay nominating her for CURE®’s 2022 Extraordinary Healer award.
Cancer Vaccine-Tecentriq Combo Elicits ‘Very Encouraging’ Outcomes in Advanced Cervical Cancer
May 10th 2022Treatment with an investigational cancer vaccine plus Tecentriq was associated with positive outcomes in patients with heavily pre-treated advanced cervical cancer, according to findings from an interim analysis of a phase 2 trial.
Zytiga-Containing Regimen Boosts Survival in Certain Patients With Prostate Cancer
May 6th 2022Treatment with androgen deprivation therapy in combination with Zytiga, docetaxel and prednisone improved radiographic progression-free survival and overall survival in patients with de novo metastatic castration-sensitive prostate cancer.